Presynaptic 5-HT1AR autoreceptors predominantly signal through Gi3 protein, mediating feedback inhibition that hampers the therapeutic efficacy of conventional antidepressants. By contrast, postsynaptic heteroreceptors mainly couple to Go, which promotes antidepressant responses. However, selectively activating heteroreceptors while bypassing the negative feedback induced by autoreceptors remains a significant challenge. Here, we characterized the Gi/o subtype signaling profiles of 5-HT1AR and determined its structures in complex with six agonists and three distinct Gi/o family proteins: GoA, Gi3, and Gz. Combined with functional analysis, we elucidated the mechanisms underlying diverse agonist recognition modes and Gi/o subtype signaling selectivity of 5-HT1AR. Furthermore, we designed a pathway-selective agonist, TMU4142, which exhibits high GoA activity while minimizing Gi3 activation. Remarkably, TMU4142 demonstrated rapid antidepressant-like effects in a mouse model of depression. Collectively, these findings suggest that distinguishing heteroreceptors from autoreceptors based on their distinct downstream Gi/o signaling pathways could be a promising strategy to develop fast-acting antidepressants.
Keywords: 5-HT(1A)R; G(i/o) subtype selectivity; antidepressant; autoreceptors; drug discovery; feedback inhibition; heteroreceptors; ligand recognition; structural pharmacology.
Copyright © 2025 Elsevier Inc. All rights reserved.